Dr Reddys Laboratories Ltd Share Holding Pattern

Home

Insights

Share Holding

₹ 27.7 Cr

Volume Transacted

(Dec 20, 2024)

206.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Promoters Holdings Over Time

Key Highlights

Mutual funds increased their stake in the company by 2.10% from March 2024 to June 2024.
Promoters decreased their stake in the company by 0.00% from March 2024 to June 2024. FIIs/FPIs decreased their stake in the company by 1.46% from March 2024 to June 2024.

Latest Shareholding

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price of Dr Reddys Laboratories Ltd

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

20 Dec 2024	1342.45	1328.95	1368	1318.35
19 Dec 2024	1326	1270.05	1330.45	1270.05
18 Dec 2024	1275.05	1267.95	1280.7	1250.1
17 Dec 2024	1248	1269.95	1270.4	1243.75
16 Dec 2024	1269.9	1246.3	1272.9	1245.25
13 Dec 2024	1246.3	1242.95	1250	1227
12 Dec 2024	1245.95	1245.9	1249.75	1226.4
11 Dec 2024	1238.45	1247.8	1247.8	1226.5
10 Dec 2024	1239.95	1254.8	1254.8	1233
09 Dec 2024	1254.8	1261.3	1261.8	1244

Date	Price (₹)
20 Dec 2024	1342.45
19 Dec 2024	1326
18 Dec 2024	1275.05
17 Dec 2024	1248
16 Dec 2024	1269.9
13 Dec 2024	1246.3
12 Dec 2024	1245.95
11 Dec 2024	1238.45
10 Dec 2024	1239.95
09 Dec 2024	1254.8

Dr Reddys Laboratories Ltd News Hub

Dr Reddys Laboratories allots 13,080 equity shares under ESOS

Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...

20 Dec 2024 09:31

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

20 Dec 2024 13:05

Dr Reddys launches immuno-oncology drug - Toripalimab in India

Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...

28 Nov 2024 09:14

Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India

Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...

28 Nov 2024 10:11

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

21 Nov 2024 10:23

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

20 Nov 2024 10:40

Document

Annual Reports

Annual Report 2024

Credit Ratings

N/A

Concalls

Aug 2024

July 2024

May 2024

Feb 2024

Nov 2023

July 2023

May 2023

Jan 2023

Nov 2022

June 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

May 2020

Jan 2020

Aug 2024

July 2024

May 2024

Feb 2024

Nov 2023

July 2023

May 2023

Jan 2023

Nov 2022

June 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

May 2020

Jan 2020

Popular Search

Dr Reddys Laboratories Ltd pe ratio

Dr Reddys Laboratories Ltd eps

Dr Reddys Laboratories Ltd share price history

Dr Reddys Laboratories Ltd dividend

Dr Reddys Laboratories Ltd market cap

Dr Reddys Laboratories Ltd pb ratio

Sun Pharmaceuticals Industries Ltd share holding pattern

Divis Laboratories Ltd share holding pattern

Cipla Ltd share holding pattern

Torrent Pharmaceuticals Ltd share holding pattern

Mankind Pharma Ltd share holding pattern

Zydus Lifesciences Ltd share holding pattern

Lupin Ltd share holding pattern

Aurobindo Pharma Ltd share holding pattern

Alkem Laboratories Ltd share holding pattern

Abbott India Ltd share holding pattern

FAQs for EPS of Dr Reddys Laboratories Ltd

On what factors does the shareholding pattern of Dr Reddys Laboratories Ltd change frequently?

The shareholding pattern of Dr Reddys Laboratories Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Dr Reddys Laboratories Ltd's shareholding pattern updated?

The Dr Reddys Laboratories Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Dr Reddys Laboratories Ltd?

Categories included in the shareholding pattern of Dr Reddys Laboratories Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Dr Reddys Laboratories Ltd important for investors?

The shareholding pattern of Dr Reddys Laboratories Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Dr Reddys Laboratories Ltd?

The latest shareholding pattern of Dr Reddys Laboratories Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.